JP2022525040A5 - - Google Patents
Info
- Publication number
- JP2022525040A5 JP2022525040A5 JP2021553070A JP2021553070A JP2022525040A5 JP 2022525040 A5 JP2022525040 A5 JP 2022525040A5 JP 2021553070 A JP2021553070 A JP 2021553070A JP 2021553070 A JP2021553070 A JP 2021553070A JP 2022525040 A5 JP2022525040 A5 JP 2022525040A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- small cell
- lung cancer
- cell lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025011556A JP2025081338A (ja) | 2019-03-08 | 2025-01-27 | 非小細胞肺がんの女性非喫煙者の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815762P | 2019-03-08 | 2019-03-08 | |
| US62/815,762 | 2019-03-08 | ||
| PCT/US2020/021615 WO2020185640A1 (en) | 2019-03-08 | 2020-03-08 | Method for treating female non-smokers with non-small cell lung cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011556A Division JP2025081338A (ja) | 2019-03-08 | 2025-01-27 | 非小細胞肺がんの女性非喫煙者の処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525040A JP2022525040A (ja) | 2022-05-11 |
| JP2022525040A5 true JP2022525040A5 (https=) | 2023-03-14 |
Family
ID=72427123
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553070A Pending JP2022525040A (ja) | 2019-03-08 | 2020-03-08 | 非小細胞肺がんの女性非喫煙者の処置方法 |
| JP2025011556A Pending JP2025081338A (ja) | 2019-03-08 | 2025-01-27 | 非小細胞肺がんの女性非喫煙者の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011556A Pending JP2025081338A (ja) | 2019-03-08 | 2025-01-27 | 非小細胞肺がんの女性非喫煙者の処置方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220168258A1 (https=) |
| EP (1) | EP3935043A4 (https=) |
| JP (2) | JP2022525040A (https=) |
| KR (1) | KR20220047208A (https=) |
| CN (2) | CN113906010A (https=) |
| AU (2) | AU2020235823A1 (https=) |
| BR (1) | BR112021017716A2 (https=) |
| CA (1) | CA3132827A1 (https=) |
| MX (1) | MX2021010745A (https=) |
| SG (1) | SG11202109705YA (https=) |
| WO (1) | WO2020185640A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008352597B2 (en) * | 2008-03-14 | 2012-03-08 | Bionumerik Pharmaceuticals, Inc. | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
| JP5667886B2 (ja) * | 2008-03-14 | 2015-02-12 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | 癌患者の生存時間を増大させるための組成物及び化合物の使用方法 |
| CA2717915A1 (en) * | 2008-03-14 | 2009-09-17 | Bionumerik Pharmaceuticals, Inc. | Chemoprotective methods and compositions |
| US20170007561A1 (en) * | 2014-08-08 | 2017-01-12 | Bionumerik Pharmaceuticals, Inc. | Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur-containing, amino acid-specific small molecules |
-
2020
- 2020-03-08 EP EP20770472.7A patent/EP3935043A4/en active Pending
- 2020-03-08 JP JP2021553070A patent/JP2022525040A/ja active Pending
- 2020-03-08 MX MX2021010745A patent/MX2021010745A/es unknown
- 2020-03-08 AU AU2020235823A patent/AU2020235823A1/en not_active Abandoned
- 2020-03-08 CN CN202080034238.XA patent/CN113906010A/zh active Pending
- 2020-03-08 KR KR1020217031523A patent/KR20220047208A/ko not_active Ceased
- 2020-03-08 SG SG11202109705Y patent/SG11202109705YA/en unknown
- 2020-03-08 BR BR112021017716A patent/BR112021017716A2/pt unknown
- 2020-03-08 CA CA3132827A patent/CA3132827A1/en active Pending
- 2020-03-08 CN CN202510278250.XA patent/CN120078760A/zh active Pending
- 2020-03-08 WO PCT/US2020/021615 patent/WO2020185640A1/en not_active Ceased
-
2021
- 2021-09-08 US US17/469,765 patent/US20220168258A1/en not_active Abandoned
-
2025
- 2025-01-27 JP JP2025011556A patent/JP2025081338A/ja active Pending
- 2025-11-12 AU AU2025267367A patent/AU2025267367A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100363004C (zh) | 喹唑啉衍生物zd6474组合吉西他滨在制备药物中的用途 | |
| JP2025511399A5 (https=) | ||
| Tomblyn et al. | Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414) | |
| US9205098B2 (en) | Anti-cancer therapies | |
| CN109069500B (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP2003533485A5 (https=) | ||
| JP2022526159A5 (https=) | ||
| JP2022525040A5 (https=) | ||
| EP1729808B1 (en) | Combination therapy with azd2171 and 5-fu and/or cpt-11 | |
| AU2006264620B2 (en) | Combination therapy of cancer with AZD2171 and gemcitabine | |
| Ajani et al. | Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas | |
| TW202241421A (zh) | 菸鹼醯胺及含有其的組合物的製藥用途 | |
| HK1096023B (en) | Combination therapy with azd2171 and 5-fu and/or cpt-11 | |
| HK1078771B (en) | Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of cancer | |
| HK1261169A1 (en) | Quinoline derivative for treating gastric cancer | |
| MXPA06008954A (en) | Anti-cancer therapies |